Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death
about
Emerging concepts in the immunopathogenesis of AIDSB7-DC, a new dendritic cell molecule with potent costimulatory properties for T cellsbcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapyGenes, tolerance and systemic autoimmunityMolecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cellsThe PD-1 pathway in tolerance and autoimmunityApoptosis: a mechanism of cell killing by influenza A and B virusesRole of tyrosine phosphorylation of HS1 in B cell antigen receptor-mediated apoptosisThe programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) miceMolecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interactionEngagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activationPD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cellsProgrammed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerSuppression of nonsense-mediated mRNA decay permits unbiased gene trapping in mouse embryonic stem cellsThe quantal theory of how the immune system discriminates between "self and non-self"PD-L1 expression in human cancers and its association with clinical outcomesA Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune CheckpointsInhibiting Immune Checkpoints for the Treatment of Bladder CancerMedical treatment for gastro-entero-pancreatic neuroendocrine tumoursCancer immunotherapy: the beginning of the end of cancer?PD-1/PD-L1 blockade in cancer treatment: perspectives and issuesPredictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysisProgrammed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleNovel technologies and emerging biomarkers for personalized cancer immunotherapyMolecular profiling in the treatment of colorectal cancer: focus on regorafenibNew developments in the management of advanced melanoma - role of pembrolizumabHuman Cancer Immunotherapy with PD-1/PD-L1 BlockadePembrolizumabNivolumab in the treatment of malignant melanoma: review of the literatureAutoimmune therapies targeting costimulation and emerging trends in multivalent therapeuticsRole of the PD-1 pathway in the immune responseThe programmed death-1 immune-suppressive pathway: barrier to antitumor immunityImmune Checkpoint Blockade in Cancer TherapyFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsImmunotherapy advances for glioblastomaNew immunotherapies targeting the PD-1 pathwayHerpesvirus exploitation of host immune inhibitory pathwaysA tonsillar PolyICLC/AT-2 SIV therapeutic vaccine maintains low viremia following antiretroviral therapy cessationT-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?Impaired Hepatitis C Virus (HCV)-Specific Effector CD8+ T Cells Undergo Massive Apoptosis in the Peripheral Blood during Acute HCV Infection and in the Liver during the Chronic Phase of Infection
P2860
Q22241984-5544B368-CEB9-4A8D-B325-E9A03854A3EBQ24291070-569A932D-2F8A-41C3-8287-FE9DC4047EDCQ24319116-A8432501-D579-4FE5-A492-03DF71C7CC77Q24615454-FC1EF566-11F3-43EA-B213-592436FEF411Q24629674-F5CAB8FA-5C5C-47CC-AC23-2555AED9F1D2Q24633549-FA681E5F-4B58-40E3-A242-9CADCBCFA841Q24646086-FEEF6028-DE93-41D9-A1BD-AD999F274FE9Q24669916-E54DDAEC-E1ED-4C09-98EC-448508030B8DQ24670319-555BF717-BA9B-4D6F-B87C-8BF806853973Q24673269-423F13F3-9C1D-4BDE-B8B0-D9C91D6CA404Q24675931-A598EDE0-FD20-46AC-8B4C-8C8F2B6D135AQ24677367-A2E6216E-283D-4EF6-9A6A-2A6A5FB89B91Q24685406-2564B45E-3DA4-42A6-A79C-B2792208C56BQ24802839-F17788B5-0ED0-461B-8227-AD8BCBE60691Q24803143-E294CED0-6E92-4535-B447-98FE817B0503Q26738361-44FDEC26-838E-4C36-9731-BA873F742E2EQ26738729-C3B2AC6E-B39C-4C9A-9075-6E1F54E5A104Q26744758-F1E0E51E-8E56-457F-A56D-618180C0E6CEQ26751659-DD193CDB-A339-4C02-9270-53E485734B6BQ26752277-10335AD8-D6BB-40F9-8B14-54960161A01EQ26768641-AE0DDE01-6CA4-46CA-A509-431FDAE062EDQ26769728-F4BE672E-36D5-4928-A48A-4B193B11672DQ26769734-7D21CF70-7793-4285-81D0-B498FEDF968EQ26770780-E0D2A24E-0715-48AA-8B91-89E804CFEC2DQ26778296-AC3C509D-9F3F-4227-9ADE-EDDC88B83226Q26781931-B3396F06-905A-4C98-8946-C53EAA4E2153Q26786108-C77ED20C-EA9B-45E8-91B4-2324DDD81BAAQ26796435-B5AAECEA-AA79-4841-828B-CC84A30D8406Q26798330-16B33A7C-403C-4E13-A4D2-31B482CF044CQ26823789-AD609D66-80C7-4EC6-9BC1-E047FFFFE608Q26828748-4B8DAAA8-B095-4947-B0DA-BFFA26808FFCQ26829847-4EE1DD88-EA49-4580-809C-A773684F51E4Q26830509-6EEFB139-7FCE-48F6-87C8-AA04281DFD3FQ26865532-D1B2D94E-10E2-437E-AA2A-6CDAA4DE164FQ26866513-FD3E8147-C3FC-42CF-8C6E-CAC28C78CE90Q27010018-E96FBCB8-2395-4561-B2EB-7DEA053C9E06Q27013680-461C15C4-1E1F-4C7E-8533-616D4F0AC997Q27319650-86FA0194-7FC4-4DFD-A646-74BB65410D8FQ27335110-808D7B07-4D20-411E-BED9-8CB4157593EAQ27487035-9E9090E8-ED6A-43CF-9449-EF0B803CA973
P2860
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Induced expression of PD-1, a ...... ly, upon programmed cell death
@ast
Induced expression of PD-1, a ...... ly, upon programmed cell death
@en
Induced expression of PD-1, a ...... ly, upon programmed cell death
@en-gb
Induced expression of PD-1, a ...... ly, upon programmed cell death
@nl
type
label
Induced expression of PD-1, a ...... ly, upon programmed cell death
@ast
Induced expression of PD-1, a ...... ly, upon programmed cell death
@en
Induced expression of PD-1, a ...... ly, upon programmed cell death
@en-gb
Induced expression of PD-1, a ...... ly, upon programmed cell death
@nl
prefLabel
Induced expression of PD-1, a ...... ly, upon programmed cell death
@ast
Induced expression of PD-1, a ...... ly, upon programmed cell death
@en
Induced expression of PD-1, a ...... ly, upon programmed cell death
@en-gb
Induced expression of PD-1, a ...... ly, upon programmed cell death
@nl
P2093
P2860
P3181
P1433
P1476
Induced expression of PD-1, a ...... ly, upon programmed cell death
@en
P2093
P2860
P304
P3181
P407
P577
1992-11-01T00:00:00Z